GPhA adds policy advisor, spokesperson
The Generic Pharmaceutical Association is adding two staffers. Senior Policy Advisor Richard Hegner joins from the National Health Policy Forum at George Washington University, where he was a research associate. Director of Media Relations Andrea Hofelich was previously majority communications director for the Senate Governmental Affairs Committee, chaired by Susan Collins (R-Maine)...
You may also be interested in...
Inovio Pharmaceuticals has reported promising initial data from its first Phase III study of its electrical current-driven DNA plasmid-based immunotherapy, VGX-3100, in virus-associated cervical dysplasia; it is heading a small group of companies evaluating novel therapies in the condition, which often advances to cancer.
In the month ahead, a key ANDA approval could come for Viatris, while additional competition to Gilead Sciences’ Truvada for PrEP is on the way in the US following Teva and Amneal’s launches.
Sensyne obtained UK regulatory approval for its SYNE-COV machine learning algorithm to assess the long-term risks of COVID-19.